NASDAQ: ESPR - Esperion Therapeutics, Inc.

Price = Avg Price + (Avg Price * CAGR EPS% / 100)
EPS = Earning Per Share
CAGR EPS = CAGR 5 EPS
Key Rate — Nøkkelrente
Excess Key Rate — Ønsket overskridelse av styringsrenten
EPS = -2.03
CAGR EPS = 9.16%
Key Rate = 0.0458
Excess Key Rate = 2
Price = 1.51 + (1.51 * 9.16% / 100) = 1.64

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Discount Ebitda / (1 + WACC) ^ 5)
Discount Ebitda(5) = -0.2445
Ebitda Yield = 0.0949
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.059
Debt = 0.298
Market Cap = 0.1551
Weight Debt = Market Cap / (Market Cap + Debt) = 0.1551 / (0.1551 + 0.298) = 0.3423
Weight Cost Debt = 100% - 0.3423 = 0.6577
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 2.6
β = -1.51
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 2.6 + -1.51 * 5.94 + 0 = -0.0635
WACC = (0.059 / 0.298) * (100% - 0.3423) * (1 - 0.21) + -0.0635 + 0.3423 = 15.56
Terminal Value = Discount (-0.2445 * (1 + 0.0949) / (15.56 - 0.0949)) = -2.14
Company Value = ∑ (-0.2445 / (1 + 15.56) ^ 5) = -0.6628
Price = (Terminal Value + Company Value) / Count shares = (-2.14 + -0.6628) / 103110000 = -27.18

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield)
Company Value = ∑ (Discount FCF / (1 + WACC) ^ 5)
Discount FCF(5) = -0.2287
FCF Yield = 0.1104
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.059
Debt = 0.298
Market Cap = 0.1551
Weight Debt = Market Cap / (Market Cap + Debt) = 0.1551 / (0.1551 + 0.298) = 0.3423
Weight Cost Debt = 100% - 0.3423 = 0.6577
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 2.6
β = -1.51
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 2.6 + -1.51 * 5.94 + 0 = -0.0635
WACC = (0.059 / 0.298) * (100% - 0.3423) * (1 - 0.21) + -0.0635 + 0.3423 = 15.56
Terminal Value = Discount (-0.2287 * (1 + 0.1104) / (15.56 - 0.1104)) = -2.72
Company Value = ∑ (-0.2287 / (1 + 15.56) ^ 5) = -0.6019
Price = (Terminal Value + Company Value) / Count shares = (-2.72 + -0.6019) / 103110000 = -32.25